Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study

Fig. 3

Health economic questionnaire data from German patients in the SAF enrolled before 08 April 2014 showing percentages of patients who visited a family doctor (), visited a medical specialist (■), and used remedies, including massage, manual therapy, and physiotherapy (▲). Percentages are related to the number of patients at the respective visit. The reporting window for the baseline visit was the last 6 months; follow-up since the last visit. Non-overlapping 95% confidence intervals (CIs) at each time point vs. baseline are denoted by * for visits to a family doctor, # for visits to a medical specialist, and ‡ for use of remedies; non-overlapping 95% Cis show statistical significance

Back to article page